1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study

Bibliographic Details
Main Authors: Kun-Hsing Yu, Shadmehr Demehri, Nga Nguyen, Leyre Zubiri, Kerry Reynolds, Alexander Gusev, Shawn Kwatra, Yevgeniy R Semenov, Nicole R LeBoeuf, Jayhyun Seo, William Lotter, Katie Roster, Wenxin Chen, Guihong Wan, Ahmad Rajesh, Hannah Rashdan
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1797630658652143616
author Kun-Hsing Yu
Shadmehr Demehri
Nga Nguyen
Leyre Zubiri
Kerry Reynolds
Alexander Gusev
Shawn Kwatra
Yevgeniy R Semenov
Nicole R LeBoeuf
Jayhyun Seo
William Lotter
Katie Roster
Wenxin Chen
Guihong Wan
Ahmad Rajesh
Hannah Rashdan
author_facet Kun-Hsing Yu
Shadmehr Demehri
Nga Nguyen
Leyre Zubiri
Kerry Reynolds
Alexander Gusev
Shawn Kwatra
Yevgeniy R Semenov
Nicole R LeBoeuf
Jayhyun Seo
William Lotter
Katie Roster
Wenxin Chen
Guihong Wan
Ahmad Rajesh
Hannah Rashdan
author_sort Kun-Hsing Yu
collection DOAJ
first_indexed 2024-03-11T11:11:19Z
format Article
id doaj.art-2db26149663644138c8caab863d52e03
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-11T11:11:19Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-2db26149663644138c8caab863d52e032023-11-12T02:25:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.12411241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level studyKun-Hsing Yu0Shadmehr Demehri1Nga Nguyen2Leyre Zubiri3Kerry Reynolds4Alexander Gusev5Shawn Kwatra6Yevgeniy R Semenov7Nicole R LeBoeuf8Jayhyun Seo9William Lotter10Katie Roster11Wenxin Chen12Guihong Wan13Ahmad Rajesh14Hannah Rashdan152Harvard Medical School, Boston, MA, USADepartment of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USADepartment of Health Education, Faculty of Social Science, Behavior and Health Education, Hanoi University of Public Health, Hanoi, Vietnam1MGH, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USADepartment of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts, USA4Johns Hopkins University, Baltimore, MD, USADepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA2Dana Farber Cancer Institute, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USA1Dana-Farber Cancer Institute, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USA
spellingShingle Kun-Hsing Yu
Shadmehr Demehri
Nga Nguyen
Leyre Zubiri
Kerry Reynolds
Alexander Gusev
Shawn Kwatra
Yevgeniy R Semenov
Nicole R LeBoeuf
Jayhyun Seo
William Lotter
Katie Roster
Wenxin Chen
Guihong Wan
Ahmad Rajesh
Hannah Rashdan
1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study
Journal for ImmunoTherapy of Cancer
title 1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study
title_full 1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study
title_fullStr 1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study
title_full_unstemmed 1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study
title_short 1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study
title_sort 1241 clusters of multi organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients a population level study
work_keys_str_mv AT kunhsingyu 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT shadmehrdemehri 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT nganguyen 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT leyrezubiri 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT kerryreynolds 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT alexandergusev 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT shawnkwatra 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT yevgeniyrsemenov 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT nicolerleboeuf 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT jayhyunseo 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT williamlotter 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT katieroster 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT wenxinchen 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT guihongwan 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT ahmadrajesh 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy
AT hannahrashdan 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy